Hey, I found the following interview on twitter with Paul Hopper from IMU. I'm not invested in IMU nor interested in it but some of the conversation is based on Bio tech companies, phase 1&2&3 trials, and outcomes etc is really useful if you're invested in BOT. Bear in mind IMU works with cancer so most likely harder to achieve Phase 2 or 3.
If Phase 2 results for BTX 1503 (serve acne) are top-shelf then expect a large offer from big pharma. I'm guessing that's why Vince has the $500k bonus if a deal is made within 6 months stipulated in his contract. Hard to say how much value could be put on BOT but surely a deal between $1-2b AUD could be made, the Permetrex technology is worth big $$$ in itself
Hey, I found the following interview on twitter with Paul Hopper...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.020(6.15%) |
Mkt cap ! $624.4M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 34.5¢ | 32.5¢ | $2.676M | 7.955M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 48210 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |